Zhongda Hospital, Southeast University
Nanjing, Jiangsu, 210009, China
NCT Number: NCT04359251
This was a multi-center prospective study. All consecutive severe cases of COVID-19 whose PO2/FiO2<300mmHg with invasive ventilation admitted to 5 fixed-point receive COVID-19 patients hospitals in Wuhan from 5 March to 15 March 2020 were included. Epidemiological, clinical data, lung mechanics, artery blood gas test and hemodynamics at three methods to titrate PEEP, optimizing oxygenation, optimizing compliance, ARDSnet. The study was approved by the Ethics Committee of Zhongda Hsopital, Southeast University.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210009, China
After PEEP titration, PEEP settings could be set by optimizing oxygenation, optimizing compliance, ARDSnet.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gas exchanges measurement at different PEEP
lung mechanics measurement at different PEEP
Hemodynamics changes measurement at different PEEP
Time frame: 20 minutes
the respiratory system compliance was compared among three groups
Time frame: 20 minutes
P/Fwere compared among three groups
Time frame: 20 minutes
MAP were compared among three groups
Southeast University, China
Other
Avoiding High PEEP in COVID-19 Induced ARDS: a Multi-center Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04402879
ARDS, Acute Respiratory Distress Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT07466524
Acute Respiratory Distress Syndrome, COVID-19
Ann Arbor, Michigan, United States
View Trial DetailsNCT04316884
Acute Kidney Injury, Acute Respiratory Distress Syndrome
Uppsala, Uppsala County, Sweden
View Trial DetailsNCT04358939
Acute Respiratory Distress Syndrome, COVID-19
Aix-en-Provence, France
View Trial Details